Journal article
Factors associated with poor adherence to antiviral treatment for hepatitis B
N Allard, A Dev, J Dwyer, G Srivatsa, A Thompson, B Cowie
Journal of Viral Hepatitis | Published : 2017
DOI: 10.1111/jvh.12582
Abstract
Antiviral therapy for hepatitis B is effective and reduces the risk of progression to cirrhosis and liver cancer but is often required for an indefinite duration. Treatment adherence is important to prevent the development of resistance and optimize outcomes. Pharmacy adherence measures can be used to assess treatment adherence, with the medication possession ratio being less susceptible to bias than physician- or self-reported adherence. The aim of this study was to measure adherence in public hospital outpatients over a 3-year period and to examine factors associated with nonadherence. A retrospective study of pharmacy records of patients dispensed antiviral therapy for hepatitis B from fo..
View full abstractGrants
Funding Acknowledgements
NA is supported by an APA scholarship from the University of Melbourne. The authors acknowledge the assistance of the Statistical Consulting Centre of University of Melbourne. Funding was for the project provided by the RMH home lottery grant.